On January 26, 2025, as the nation celebrated Republic Day, four incredible blood donors chose to celebrate in a way that gave life and hope. They came forward to support our HLA Matched Transfusion initiative, a specialised program that makes transfusions safer and more effective for children living with thalassemia.
Like many families affected by thalassemia, Arpitha and Kanthraj were unaware of the genetic disorder affecting their children. Each child developed complications and did not survive beyond the first year. Despite multiple hospital visits, not a single doctor informed them about Thalassemia, leaving them in the dark about its consequences.
At Sankalp India Foundation, every step we take is guided by one simple principle—to give children and young people living with thalassemia the safest and best possible care. Blood transfusions form the backbone of thalassemia management, and ensuring their safety is non-negotiable.
On their recent visit to Bengaluru, the Huron leadership team, including Mark Hussey, CEO and President, and John Kelly, CFO, along with senior leaders Costa Magas, Paul Praveen, Gulpreet Kaur, Anand Shanty, and Kokoth, spent a day with us at Sankalp India Foundation to learn more about our work in thalassemia management, prevention, and cure.
At Sankalp India Foundation, we often meet young people whose courage inspires us every single day. One such story is that of Manjunath NR, a 24-year-old thalassemia warrior whose life reminds us why we do what we do.
At Sankalp India Foundation, we believe that every child living with thalassemia deserves timely, safe, and compassionate care. Our day care centres are built on this promise, and with each expansion, we take a step closer to reaching more families in need.
